ICAM-1 expression on human brain microvascular endothelial cells

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Leukocytes contribute to tissue damage in acute ischemic stroke.
• Intercellular adhesion molecule-1 (ICAM-1) is crucial for leukocyte migration into the brain.

Purpose of the Study:

• To compare ICAM-1 expression in human brain microvascular endothelial cells (HBMECs) versus human umbilical vein endothelial cells (HUVECs).
• To investigate the effect of cytokine or lipopolysaccharide stimulation on ICAM-1 expression.
• To evaluate the inhibitory effect of dexamethasone on ICAM-1 upregulation.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to quantify ICAM-1 expression.
• HBMECs and HUVECs were stimulated with cytokines (IL-1β, TNF) or lipopolysaccharide.
• Cells were treated with varying concentrations of dexamethasone.

Main Results:

• Constitutive surface expression of ICAM-1 was observed on both HBMECs and HUVECs.
• Cytokine or lipopolysaccharide stimulation resulted in a greater increase in ICAM-1 expression on HBMECs compared to HUVECs.
• Dexamethasone, up to 100 μM, did not inhibit cytokine-mediated ICAM-1 upregulation on HBMECs.

Conclusions:

• HBMECs exhibit a heightened response in ICAM-1 expression compared to HUVECs upon stimulation.
• The findings suggest specific endothelial cell responses in the brain relevant to ischemic stroke pathophysiology.
• Dexamethasone is ineffective in modulating ICAM-1 upregulation in this context, indicating potential limitations for its use in mitigating stroke-related inflammation via this pathway.